Company facts
- Headquarters
- London
- Most recent report
- 6-K, filed Nov 5, 2026
- Incorporated
- N/A
- Filings on record
- 311 filings
- On EDGAR
- CIK 1849296
- Fiscal year ends
- N/A
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 8 of 159
- 6-K Report a foreign issuer made public elsewhere Nov 5, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 6, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 29, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 28, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 27, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 23, 2026
Prospectuses and Registrations 8 of 26
- 424B5 Prospectus supplement for an offering Feb 17, 2026
- 424B5 Prospectus supplement for an offering Feb 12, 2026
- 424B5 Prospectus supplement for an offering Feb 11, 2026
- F-3 Feb 2, 2026
- 424B5 Prospectus supplement for an offering Jun 11, 2025
- 424B5 Prospectus supplement for an offering Dec 20, 2023
- 424B5 Prospectus supplement for an offering Dec 18, 2023
- 424B5 Prospectus supplement for an offering Oct 31, 2023
Ownership 8 of 53
- 4/A Insider reported a trade, amended Aug 7, 2026
- 4/A Insider reported a trade, amended Aug 7, 2026
- 4/A Insider reported a trade, amended Aug 7, 2026
- 4/A Insider reported a trade, amended Aug 7, 2026
- 4/A Insider reported a trade, amended Aug 7, 2026
- 4/A Insider reported a trade, amended Aug 7, 2026
- 4/A Insider reported a trade, amended Aug 7, 2026
- 4 Insider reported a trade Jul 29, 2026
Other 8 of 73
- 20-F/A Annual report, foreign issuer, amended Aug 7, 2026
- EFFECT Notice that a registration became effective Feb 10, 2026
- UPLOAD Comment letter from SEC staff Feb 6, 2026
- CORRESP Reply to SEC staff Feb 6, 2026
- 20-F/A Annual report, foreign issuer, amended Aug 12, 2025
- NT 20-F Jul 31, 2024
- 20-F/A Annual report, foreign issuer, amended Aug 25, 2023
- NT 20-F Jul 31, 2023
Everything here comes from OKYO Pharma Ltd's own filings on SEC EDGAR. The filing list is rechecked every hour.